Showing results (11-20 of 53) with videos related to

Sort By:
Pageof 6
Cancer Genomics & Proteomics|June 22, 2022
Prediction of Angiopoietin-like Protein 4-related Signaling Pathways in Cholangiocarcinoma CellsTin May Aung, Atit Silsirivanit, Apinya Jusakul, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|July 20, 2021
Arctigenin inhibits cholangiocarcinoma progression by regulating cell migration and cell viability via the N-cadherin and apoptosis pathwaySutthiwan Janthamala, Apinya Jusakul, Sarinya Kongpetch, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|October 16, 2025
Discrimination of urine infrared spectral biomarkers for early-stage chronic kidney disease patients using attenuated total reflectance fourier transform infrared spectrometryPatipat Rachawangmuang, Patutong Chatchawal, Patcharaporn Tippayawat, et al.
Frontiers in Molecular Biosciences|March 7, 2024
Iron-induced kidney cell damage: insights into molecular mechanisms and potential diagnostic significance of urinary FTLSoraya Punchai, Nachayada Chaiyagot, Nadthanicha Artkaew, et al.
Peerj|January 24, 2022
Therapeutic targeting of ARID1A and PI3K/AKT pathway alterations in cholangiocarcinomaSupharada Tessiri, Anchalee Techasen, Sarinya Kongpetch, et al.
Peerj|May 7, 2025
Alleles of <i>CYP3A5</i> and their association with renal function in chronic kidney diseaseOnnapa Kongphan, Worachart Lert-Itthiporn, Ubon Cha'on, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|January 6, 2015
Association of CYP39A1, RUNX2 and oxidized alpha-1 antitrypsin expression in relation to cholangiocarcinoma progressionChakkaphan Khenjanta, Raynoo Thanan, Apinya Jusakul, et al.
Best Practice & Research. Clinical Gastroenterology|May 13, 2015
Pathogenesis of cholangiocarcinoma: From genetics to signalling pathwaysSarinya Kongpetch, Apinya Jusakul, Choon Kiat Ong, et al.
Pageof 6